Abbott Laboratories (ABT) 10-Q Filing 2026-03-31

📊 Key Financial Highlights

Revenue

$22.22B

2026-03-31

Net Income

$-4.00M

2026-03-31

EPS (Basic)

$-0.11

Per share

Total Assets

$164.79B

Balance sheet

Operating Cash Flow

$-179.00M

Cash flow statement

Gross Margin

11.5%

Profitability

📋 Filing Information

Company	Abbott Laboratories
Ticker	ABT
Form Type	10-Q
Period of Report	2026-03-31
Filing Date	2026-04-22
Sector	Healthcare
CIK Number	0000012927

📄 View Full SEC Filing →

📝 Filing Summary

            This is a Quarterly Report (10-Q) filed by Abbott Laboratories with the SEC. It covers the quarter ending 2026-03-31 and includes unaudited financial statements and management discussion.
        

Abbott Laboratories (ABT) operates in the Healthcare sector. The company reported revenue of $22.22B and net income of $-4.00M for the period ending 2026-03-31. The filing was submitted to the Securities and Exchange Commission (SEC) on 2026-04-22.

Investors and analysts use 10-Q filings to assess financial health, identify trends, and make investment decisions. Key areas to review include revenue growth, profit margins, cash flow generation, and management's outlook.

🔗 Explore More on emfls.github.io

Discover more financial analysis and guides:

🇰🇷 Korean Stock Analysis ₿ Crypto Reports 📊 All SEC Filings ✈️ Travel Guides 🎮 QuickPlay Arcade